HuGE Literature Finder
Records
1
-
4
Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 2019 2 49 (7): 890-903. Bank Steffen, Julsgaard Mette, Abed Osama Karim, Burisch Johan, Broder Brodersen Jacob, Pedersen Natalia Konstantinovich, Gouliaev Anja, Ajan Rullah, Nytoft Rasmussen Ditlev, Honore Grauslund Camilla, Roug Stine, Galsgaard Julie, Sprogøe Høyer Finsen David, Lindby Karoline, , Sørensen Jeanette, Larsen Lone, Rohr Andersen Malene, Brandslund Ivan, Thomassen Mads, Green Anders, Bo Bojesen Anders, Bek Sørensen Signe, Vogel Ulla, Andersen Vibe |
Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy. The pharmacogenomics journal 2017 Jan . Bank S, Andersen P S, Burisch J, Pedersen N, Roug S, Galsgaard J, Turino S Y, Brodersen J B, Rashid S, Rasmussen B K, Avlund S, Olesen T B, Hoffmann H J, Nexø B A, Sode J, Vogel U, Andersen |
Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort. PloS one 2015 10 (12): e0145302. Bank Steffen, Andersen Paal Skytt, Burisch Johan, Pedersen Natalia, Roug Stine, Galsgaard Julied, Ydegaard Turino Stine, Broder Brodersen Jacob, Rashid Shaista, Kaiser Rasmussen Britt, Avlund Sara, Bastholm Olesen Thomas, Hoffmann Hans Jürgen, Andersen Nexø Bjørn, Sode Jacob, Vogel Ulla, Andersen Vibe |
IL18 polymorphism is associated with an increased risk of Crohn's disease. Journal of gastroenterology 2002 Nov 37 Suppl 14 (): 111-6. Tamura Kazuo, Fukuda Yoshihiro, Sashio Hiroko, Takeda Naohisa, Bamba Hiroko, Kosaka Tadashi, Fukui Shin, Sawada Koji, Tamura Kazutami, Satomi Masamichi, Yamada Takahiro, Yamamura Takehira, Yamamoto Yoshihiro, Furuyama Jun-ichi, Okamura Haruki, Shimoyama Takas |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: